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Executive Summary
About this Executive Summary 
This comprehensive executive summary reports on a case study designed to demonstrate the application of 
a number of the key concepts and methods developed in the INTEGRATE-HTA project to the assessment of 
complex technologies. The case study focuses on models of home based palliative care with and without 
an additional element of caregiver support, known as reinforced and non-reinforced home based palliative 
care respectively. 
What is already known about the topic 
 	 With changing disease patterns in Europe, increasingly complex health care technologies, such as palliative 
care, have gained importance. 
 	 Current HTA methods rarely take account of wider legal, ethical and socio-cultural issues or context and im-
plementation and are not adequately equipped to assess highly complex technologies, despite considerable 
progress in recent years. As a result, HTA is rarely applied to highly complex health technologies.
What this case study report adds 
 	 The INTEGRATE-HTA project developed concepts and methods for the assessment of complex technologies, ta-
king into account legal, ethical and socio-cultural issues as well as context and implementation.
 	 This case study is designed to demonstrate the application of a number of the key concepts and methods de-
veloped in the INTEGRATE-HTA project to home based palliative care, with and without an additional element 
of caregiver support, as an example of a complex technology; known as “reinforced” and “non-reinforced” 
home based palliative care respectively. 
 	 The INTEGRATE-HTA model, developed to enable integration of relevant assessment aspects, is used to structure 
this report. 
 	 The case study reports on the application of some of the concepts and methods developed within the IN-
TEGRATE-HTA project to the assessment of effectiveness as well as economic, sociocultural, ethical, and legal 
aspects; patient preferences and patient-specific moderators of treatment and context and implementation 
issues related to reinforced and non-reinforced home based palliative care.
 	 The highly complex nature of reinforced and non-reinforced home based palliative care is illustrated through 
an assessment of complexity characteristics.
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 	 The case study also involved extensive lay and professional stakeholder involvement, using a variety of me-
thods, to inform the HTA process at key stages throughout the project. 
 	 Key messages are highlighted for both HTA research and for palliative care. 
The implications for research and practice
 	 The concepts and methods developed in the INTEGRATE-HTA project have been shown to be feasible and to 
have the potential to offer added value, but require further development and application in the assessment 
of other complex technologies.
 	 Reinforced and non-reinforced models palliative care are highly complex. The case study findings offer 
some insights into their effectiveness as well as economic, sociocultural, ethical, and legal issues; patient 
preferences and patient-specific moderators of treatment as well as context and implementation issues.
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Foreword for the INTEGRATE-HTA Case Study
Professor Sheila Payne
Emeritus Professor, Lancaster University, UK
You may have noticed that family members are central to all aspects of our lives, from nurturing babies and 
young children to supporting frail older people.  The availability of family members is even more important 
during periods of sickness and disability.  Evidence suggests that they are crucial in supporting patients throug-
hout advanced illness until death, offering to facilitate preferences such as a home death but little is known 
about how best to support them. Within Europe there are approximately 100 million family carers who expe-
rience considerable physical, psychological, social and financial challenges, and provide in total considerably 
more care than that delivered by health care workers within national health care systems. According to NICE 
(2004), family carers refer to all people with a close social and emotional bond, not just those related by kinship 
or marriage.
The case study focusing on home based palliative care, undertaken within the context of the INTEGRATE-HTA 
project, is therefore greatly welcomed.  The case study focuses on home care, especially the additional support 
required by family carers to maintain a person with advanced disease in their home (called 'reinforced' home 
based palliative care). This is extremely topical and relevant to the work of clinicians based in primary care and 
also to hospital practitioners who need to discharge patients nearing the end of life to the care of their family 
members.  A key main policy driver in the UK and many other European countries is to implement accessible and 
timely home based palliative and end of life care, to reduce the number of patients dying in hospitals. This is 
based on the assumption that most patients prefer to die at home and that hospital deaths are both more costly 
and potentially offer less quality on a number of indicators. Sustaining the ability of family carers to continue 
to provide care at home is therefore crucial.  One of the major reasons for a break down in caregiving near the 
end of life is excessive strain and burden upon family carers.  
The case study offers insights using novel HTA methodology which will be relevant to all those planning, deli-
vering and developing new interventions to improve how we might help to prevent this.  
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Table of contents
 List of abbreviations ............................................................................................7 
 List of Tables ......................................................................................................7
 List of Figures .....................................................................................................7
 List of Boxes.......................................................................................................7
1  ABOUT THE CASE STUDY  .........................................................................................9
1.1  Purpose of the case study:  A ‘Demonstration HTA’ .....................................................9
1.2  Audiences for the case study .................................................................................9
1.3  England as the context for the palliative care case study .............................................9
2  ABOUT THE INTEGRATE- HTA PROJECT ........................................................................9
2.1  Background  ......................................................................................................9
2.2  Aims of the INTEGRATE-HTA project ..........................................................................9
2.3  Choice of home based palliative care as an example of a complex intervention .............10
2.4  Expanding the evidence base about models of palliative care ....................................10
2.5  The overall research question ..............................................................................10
2.6   Reinforced models of home based palliative care ....................................................10
2.7  Non-reinforced models of home based palliative care ..............................................10
2.8  Differences between reinforced and non-reinforced models  
 of home based palliative care .............................................................................11
2.9   Methods – the INTEGRATE- HTA model ...................................................................12
2.9.1   Step 1 - Definition of the HTA objective and technology ............................................12
2.9.2  Step 2 - Creation of a logic model to define evidence needs ......................................12
2.9.3  Step 3 - Evidence assessment ..............................................................................12
2.9.4   Step 4 – Mapping of the evidence ........................................................................13
2.9.5  How to read the extended logic model to assist decision making ...............................14
2.9.6   Step 5 - HTA conclusion  .....................................................................................17
3  RESULTS...........................................................................................................18
3.1  Key results of the case study for HTA ......................................................................18
3.2  Key results of the case study for palliative care  ......................................................18
4  DISCUSSION ......................................................................................................18
4.1   Key strengths of the case study  ...........................................................................18
4.2   Key limitations of the case study  .........................................................................18
5  CONCLUSIONS ....................................................................................................22
6  RECOMMENDATIONS FOR HTA .................................................................................22
7  KEY MESSAGES AND RECOMMENDATIONS FOR PALLIATIVE CARE .......................................24
8  REFERENCES  ....................................................................................................27
9  ACKNOWLEDGEMENTS ..........................................................................................29
7 |
List of abbreviations
CICI Context and Implementation for Complex Intervention
Cope Committee on Publications Ethics
HBPC Home Based Palliative Care
HTA Health Technology Assessment
MCDA Multiple Criteria Decision Analysis
NHS National Health Service
PSS Personal Social Services 
rHBPC Reinforced Home Based Palliative Care
SAP  Stakeholder Advisory Panel
TIDiER Template for Intervention Description and Replication  
UK United Kingdom
List of Tables
Table 1: Definition of research terms ........................................................................................... 11
Table 2: The complexity characteristics of reinforced home based palliative care .................................. 15
List of Figures
Figure 1: Structure of HTA research question taking the HTA results into account ................................... 14
Figure 2: The extended logic model to assist decision making showing the assessment results on  
Reinforced models of palliative care ............................................................................... 16
List of Boxes
Box 1: Key results of the case study for HTA ................................................................................... 17
Box 2: Key results of the case study for palliative care ..................................................................... 19
Box 3: Conclusions for HTA ......................................................................................................... 22
Box 4: Conclusions for palliative care ........................................................................................... 22
Box 5: Recommendations for HTA ................................................................................................ 23
Box 6: Key messages and recommendations for palliative care  ......................................................... 25
 Integrated assessment of home based palliative care  
with and without reinforced caregiver support:  
 
‘A demonstration of INTEGRATE-HTA methodological guidances’ –  
Executive Summary  
9 |
laborators in Lithuania and Poland. A rapid applicabi-
lity assessment was conducted to assess the applica-
bility of HTA findings inthe U.K., Poland and Germany. 
2  ABOUT THE INTEGRATE- 
HTA PROJECT
2.1  BACKGROUND 
Health Technology Assessment (HTA) is an important 
tool to support health policy decision making, for ex-
ample whether or not to reimburse certain health 
technologies. However, HTAs usually focus primarily 
on summarising evidence about costs and effective-
ness, often paying less attention to the assessment 
of wider issues, including, for example, ethical, so-
cio-cultural and legal issues. Furthermore, HTA is 
also sub-optimally equipped for taking into account 
important elements such as context, implementa-
tion, patient characteristics and interactions which 
are often key factors when assessing complex health 
technologies. 
Complex health technologies include multiple per-
spectives from the many different stakeholders, 
indeterminate phenomena, uncertain causality, 
unpredictable outcomes and time/path dependen-
ce (historicity). For complex technologies decisi-
on-makers need assessment of information to be 
conducted and presented in an integrated way and 
integration needs to start from the beginning of the 
assessment.
2.2  AIMS OF THE INTEGRATE-HTA 
PROJECT
The INTEGRATE-HTA project aims to develop concepts 
and methods for a comprehensive, patient-centred, 
and integrated assessment of complex technologies 
that considers
 	 effectiveness and economic, socio-cultural, ethical, 
and legal issues,
 	 patient preferences and patient-specific moderators 
of treatment,
 	 context and implementation issues.
1 ABOUT THE CASE STUDY 
1.1 PURPOSE OF THE CASE STUDY:  
A ‘DEMONSTRATION HTA’
This case study is a so-called ‘Demonstration-HTA’, 
which is used to demonstrate the application and inte-
gration of some key concepts and methods developed 
within the INTEGRATE-HTA project to reinforced home 
based palliative care as the selected complex health 
technology. This aims to show the feasibility and value 
of the concepts and methods developed within the 
INTEGRATE-HTA project.
 The case study provides a synthesis of a broad range 
of evidence that can be used by those commissioning 
and developing palliative care services to support de-
cision making in a very complex field.
 
1.2  AUDIENCES FOR THE CASE  
STUDY
This case study report may be of interest to:
 	 those involved in Health Technology Assessment 
(HTA) as it demonstrates the application of some of 
the key concepts and methods developed in the IN-
TEGRATE-HTA project to the assessment of reinforced 
and non-reinforced home based palliative care as 
one complex technology. 
 	 the palliative care community (i.e. those commissio-
ning, delivering and using palliative care services) as 
it draws together a range of heterogeneous evidence 
that may assist decision making in a complex area of 
health care. 
1.3 ENGLAND AS THE CONTEXT FOR 
THE PALLIATIVE CARE CASE 
STUDY
England was selected as the context for the case study 
because palliative care policy and services are com-
paratively well-developed (Centeno et al., 2013). To 
enhance the international relevance of the findings, 
in the early (scoping) stages of the case study, infor-
mation was also gathered from stakeholders in the 
five INTEGRATE-HTA project partner countries: England, 
Germany, Italy, the Netherlands, Norway and our col-
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2.3 CHOICE OF HOME BASED  
PALLIATIVE CARE AS AN  
EXAMPLE OF A COMPLEX  
INTERVENTION
A range of different models of palliative care service 
provision1 are developing in different countries across 
Europe as many patients prefer to be cared for, and 
die, in their own home. Home based palliative care in-
terventions, including both reinforced and non-rein-
forced models, are highly complex. The philosophy of 
individualised care means that home based models of 
palliative care involve a range of multifaceted tailored 
and flexible services; the effects of which are of un-
certain causality.  Furthermore, multiple stakeholders 
and unpredictable outcomes add to the complexity of 
palliative care. 
2.4 EXPANDING THE EVIDENCE 
BASE ABOUT MODELS OF  
PALLIATIVE CARE
Some information about the effectiveness and cost ef-
fectiveness of models of palliative care exists. Howe-
ver, in addition to evidence about effectiveness and 
cost-effectiveness, policy makers also need informati-
on about the advantages and disadvantages of diffe-
rent models with regard to socio-cultural, ethical, and 
legal issues, patient preferences and patient-specific 
moderators of treatment. Although not traditionally 
seen as part of HTA, there is also a need to consider 
issues relating to context and implementation. These 
issues are important if policy makers are to choose the 
best palliative care provision for patients and their 
families as services continue to be developed and ex-
panded in different ways across Europe. 
2.5 THE OVERALL RESEARCH  
QUESTION
The research question reflects the intention of the IN-
TEGRATE-HTA project to develop concepts and methods 
for a comprehensive, patient–centred, and integrated 
assessment of complex technologies. The case study 
focuses on informing the following question: 
Are reinforced models of home based palliative care 
acceptable, feasible, appropriate, meaningful, effecti-
ve, cost-effective models for providing patient-centred 
palliative care (compared to non-reinforced models of 
home based palliative care) in adults (defined as tho-
se aged 18 years old and over) and their families? 
The focus on feasibility, appropriateness, mea-
ningfulness and effectiveness (rather than on each 
individual element of assessment (i.e. ethical, 
socio-cultural, legal issues etc.), is intended to allow 
consideration of the evidence in a more integrated 
manner. Feasibility, appropriateness, meaningfulness 
and acceptability within this overall research question 
are interpreted as defined by the Joanna Briggs Insti-
tute and the definitions of all terms are summarised 
in Table 1.
2.6  REINFORCED MODELS OF 
HOME BASED PALLIATIVE CARE
‘Reinforced models of home based palliative care’ (rH-
BPC) refers to “existing home palliative care with an 
additional component of caregiver support” (Gomes 
et al 2013 p.19). Reinforced models of home care will 
always include an intentional and explicit attempt to 
support informal (i.e. not professional) carers in ad-
dition to the care given to patients. ‘Support’ is any 
psycho-educational intervention aimed at providing 
assistance to carers (e.g. individual or group counsel-
ling, education, advice or respite services which al-
leviate burden). This support may aim to prepare the 
caregiver to provide future patient care or address the 
psychological health burden experienced by the infor-
mal caregiver. Consequently, reinforced models do not 
include a single well defined intervention and some 
interventions to support informal carers are similar 
to those that may be provided within non-reinforced 
models.
2.7  NON-REINFORCED MODELS OF 
HOME BASED PALLIATIVE CARE
Non-reinforced models of home based palliative care 
(HBPC) do not include an intentional and explicit ad-
ditional component of caregiver support. Non-rein-
forced models primarily focus on patients, though 
aspects of care may also be directed towards carers, 
1  The term ‘model’ of palliative care is defined with regard to its structure only as ‘who delivers (e.g. professionals, paid carers) the intervention 
(specialist or generalist palliative care), where (setting – e.g. hospital), to whom (care recipients), when (i.e. timing and duration), how (e.g. 
face to face) and for what purpose (i.e. expected outcomes)?” 
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Table 1: Definition of research terms.
Criterion of Interest Description
	   Effectiveness is defined as “The benefit (e.g. to health outcomes) of using a technology for a par-
ticular problem under general or routine conditions, for example, by a physician in 
a community hospital or by a patient at home” (INAHTA, 2015) Clinical effectiveness 
is defined as “The extent to which a specific intervention, procedure, regimen, or 
service does what it is intended to do under ordinary circumstances, rather than 
controlled conditions. Or more specifically, the evaluation of benefit to risk of an in-
tervention, in a standard clinical setting, using outcomes measuring issues of import-
ance to patients (e.g. ability to do daily activities, longer life, etc.)” (INAHTA 2015).
	   Cost effectiveness is defined as an economic evaluation consisting of comparing various options, in 
which costs are measured in monetary units, then aggregated, and outcomes are 
expressed in natural (non-monetary) units (INAHTA 2015).
	   Acceptability is defined as being agreeable to defined population groups, often those benefiting 
from , or target groups affected by, the intervention, those implementing an inter-
vention and society at large (Joann Briggs Institute 2014).
	   Meaningfulness is defined as “the extent to which an intervention or activity is positively experienced by 
the patient. Meaningfulness relates to the personal experience, opinions, values, thoughts, 
beliefs and interpretations of patients or clients” (Joanna Briggs Institute 2014).
	   Appropriateness is defined as “the extent to which an intervention or activity fits with or is apt in a 
situation. Clinical appropriateness is about how an activity or intervention relates to 
the context in which care is given (Joanna Briggs Institute 2014). 
	   Feasibility is defined as “the extent to which an activity is practical and practicable. Clinical fea-
sibility is about whether or not an activity or intervention is physically, culturally or 
financially practical or possible within a given context” (Joanna Briggs Institute 2014). 
	   Implementation is defined as “process, constellation of processes or means of assimilating or putting 
into use an intervention - either evidence-based or theory-based – in an organisati-
on or a setting” (Pfadenhauer et al., 2016).
usually on an ad hoc basis rather than as specific 
planned intervention. In accordance with Gomes et 
al’s (2013 p.10) definition, these home based mo-
dels provide physical and psychological care to sup-
port patients or their family carers, or both, outside 
of hospitals and other institutional settings. Patients 
usually have severe or advanced disease (malignant 
or non-malignant), which is no longer responding to 
curative/maintenance treatment. 
2.8  DIFFERENCES BETWEEN  
REINFORCED AND NON- 
REINFORCED MODELS OF 
HOME BASED PALLIATIVE CARE
Reinforced models of home based palliative care 
include an additional caregiver intervention within 
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an existing home care system. As such, similarities 
between reinforced and non-reinforced models of 
palliative care are inevitable. This similarity is also 
partly due to the holistic nature of palliative care 
which address the needs of the patient and their 
family in both reinforced and non-reinforced mo-
dels, albeit that in the latter, caregiver interven-
tions are ad hoc rather than planned, deliberate 
interventions. 
2.9  METHODS – THE INTEGRATE- 
HTA MODEL
The INTEGRATE-HTA Model (Wahlster et al., 2016) 
was developed to integrate all assessment aspects 
in HTAs of complex technologies. This five step mo-
del is used as a framework to present the case study 
results in this report. 
2.9.1  Step 1 - Definition of the HTA  
objective and technology
Step 1 assists in the definition of the HTA objective 
and identification of the technologies under study. 
2.9.2  Step 2 - Creation of a logic model 
to define evidence needs
Step 2 presents a specific logic model (Rohwer et al., 
2016) (i.e. a conceptual model) for reinforced and 
non-reinforced home based palliative care which 
identifies important elements and guides evidence 
collection in the HTA. 
Together Steps 1 and 2 assist project scoping (plan-
ning) to focus the HTA on reinforced and non-rein-
forced models of home based palliative care. To iden-
tify priorities in palliative care, consultations took 
place with 132 adult stakeholders (including commis-
sioners, professionals, academics, patients and ca-
rers) across seven countries (England, Germany, Italy, 
Lithuania, the Netherlands, Norway and Poland). To 
ensure that the project findings have international 
relevance, we focused on issues of shared concern to 
stakeholders in the countries involved in the project. 
Although variability exists in palliative care services 
across Europe, four common themes were identified 
across all seven countries. Themes included recogniti-
on of palliative care needs; funding; the organisation 
of palliative care; and professionals' training. Within 
the four themes, 23 issues were common to three or 
more countries, including the need to increase home 
care provision and provide training and support to fa-
mily carers. 
A review of review level evidence about models of pal-
liative care was completed at the same time as the 
stakeholder consultations. Most evidence relates to 
specialist models of palliative care, notably home ba-
sed palliative care. With greater understanding of the 
evidence base and stakeholder views of the key issues 
in palliative care, reinforced and non-reinforced mo-
dels of home care were selected as the focus for the 
application of the INTEGRATE-HTA project methodolo-
gical guidance. 
The choice of home based models of palliative care 
reflects patient preferences for home care/death along 
with policy initiatives to increase the availability of 
home palliative care/death across several countries 
involved in the project.  
Reinforced models of home based palliative care ex-
plicitly address two of the issues raised by Stakeholder 
Advisory Panels (SAPs): the need for caregiver training/
support and to increase home care provision. Additio-
nally, reinforced models reflect the philosophy of pal-
liative care in considering the patient and caregiver as 
a unit of care. 
2.9.3  Step 3 - Evidence assessment
Step 3 involves the application of the concepts and 
methods used, including further stakeholder consul-
tation, to identify, collect and synthesise evidence for 
specific aspects of the HTA as follows:
Effectiveness - To compare reinforced with non-rein-
forced home based palliative care interventions, Go-
mes et al’s (2013) systematic review was updated as 
part of the INTEGRATE-HTA project guidance to assess 
effectiveness aspects (Burns et al., 2016). Harvest 
plots were created to portray heterogeneous evidence 
in a clear, transparent way as meta-analysis was less 
appropriate. The harvest plots were used as a basis for 
a gap-analysis of the existing literature, which was 
subsequently used to inform individual semi-struc-
tured telephone consultations with four professional 
stakeholders from three countries (England, Germany 
and the Netherlands).
Economics - The economic analysis is based on a 
reinforced model of palliative home care, developed 
using a systems approach according to the INTEGRA-
TE-HTA project guidance for economic modelling of 
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complex interventions in complex settings (Chilcott et 
al.,2016). The marginal impact on resource use and 
costs were modelled and should be considered in con-
junction with the summary of effectiveness (presented 
separately). Evidence informing the model is drawn 
from a review of published literature and expert jud-
gement elicited during stakeholder workshops and 
telephone based interviews. 
Ethical - Using a procedural framework, which forms 
the core content of the INTEGRATE-HTA project guidan-
ce on ethical issues (Lysdahl et al., 2016b), an assess-
ment of the complexity of, and ethical issues associa-
ted with, (reinforced) home based palliative care was 
completed by one researcher.  
The researcher (not an HTA expert and not a trained 
ethicist) used ‘reflective thoughts’ to draw on exis-
ting knowledge, palliative care literature and advice 
provided by stakeholders (i.e. patients, relatives, pro-
fessionals, academics and other involved parties) in 
seven countries during consultations at the start of 
the project. 
Socio-cultural – Some steps from the INTEGRATE-HTA 
project guidance to assess socio-cultural aspects (Mo-
zygemba et al., 2016) of HBPC and rHBPC was applied 
through consulting nine stakeholders at different as-
sessment steps. The group or individual consultations 
took part via telephone, face-to-face or via Skype. Two 
researchers (one with sociological and health sciences 
expertise (German) and one with palliative care ex-
pertise (English native speaker) were involved. The so-
cio-cultural framework was applied in all conducted 
assessment steps. Culturally heterogeneous perspecti-
ves on the identified central category “the user-pro-
fessional-relationship and decision making” could be 
identified using Cultural Theory as an example.
Legal – the INTEGRATE-HTA project guidance for asses-
sing legal aspects (Brönneke et al., 2016) associated 
with reinforced and non-reinforced home based pal-
liative care was undertaken by two researchers (one 
English, one German), experienced in health sciences, 
but with no legal training. The researchers considered 
nine legal issues generally of importance for different 
technologies in a six step process to determine the 
need for further legal advice or assistance in the HTA 
process.  
Moderators of treatment outcome - the INTEGRATE-HTA 
project guidance on identifying patient specific mo-
derators of treatment (i.e. factors that influence the 
effect of a treatment) was used (van Hoorn et al., 
2016a). A search filter specifically aimed to retrie-
ve moderators of treatment outcome was combined 
with a modified version of Gomes et al’s (2013) search 
strategy that was used in PubMed to find publications 
on home-based models of palliative care.  A critical 
appraisal checklist tool was developed and used to 
critically appraise the selected full text articles. 
Patient preferences - application of the INTEGRATE-HTA 
project guidance on identifying patient preferences 
(van Hoorn et al., 2016a) was used. A modified versi-
on of Gomes et al’s (2013) search strategy was used in 
PubMed with a search filter on patient preferences for 
treatment outcome. Publications were subsequently 
evaluated on title-abstract, and full text to determine 
whether the papers contained information on patient 
preferences for treatment outcome. A critical appraisal 
tool specifically developed for studies on patient pre-
ferences for treatment outcomes was used to assess 
quality.
A summary of the results from the assessment of both 
patient preferences and moderators of treatment out-
come was presented to an advisory panel that con-
sisted of two ex-carers and five experienced pallia-
tive care nurses. The panel were asked to relate the 
findings to their daily practice: that is, to determi-
ne whether the findings made sense and were not 
missing important issues, whether the findings were 
usable and relevant. 
Context and implementation - a qualitative syste-
matic review of contextual barriers and facilitators 
to the implementation of home-based palliative care 
in Europe used the Context and Implementation for 
Complex Intervention (CICI) framework (Pfadenhauer 
et al., 2016) in evidence synthesis using the “best-fit” 
framework synthesis method.
Within Step 3, reinforced home based palliative care 
demonstrates all the described aspects of complexity, 
including multiple perspectives from the many diffe-
rent stakeholders involved, indeterminate phenomena, 
uncertain causality, unpredictable outcomes and time/
path dependence (historicity) (see Table 2).
2.9.4  Step 4 – Mapping of the evidence
Step 4 involved extracting evidence from the evidence 
summaries and assigning this to the six assessment 
criteria (effectiveness, meaningfulness, acceptability 
etc.) (See Figure 1). Summary tables of the evidence 
informing each assessment criterion were developed 
in preparation for decision making. Each table provi-
ded a summary of the evidence that informs a speci-
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Figure 1  Structure of HTA research question taking the HTA results into account.
	 Caregiver
	 Quality of life
	 Response Outcomes
	 Satisfaction with care
	 Psychological health  
(plus preferences) 
	 Patients 
	 Pain
	 Symptom control
	 Quality of life 
Psycological health
	 Hospitalisation
	 Response
	 Satiscfaction with care
	 Death at home (plus preferences) 
  EFFECTIVENESS  
	 Costs per patient
	 Resources impact (e.g. Specialist 
Nurse time)
	 Budget impact
  ECONOMICS  
	 Changing roles and relationships  
for caregiver (ethical)
	 Changing roles and relationships  
for patients (ethical)
	 Autonomy and shared decision 
making (legal, ethical, preferences) 
	 Location of death (preferences) 
	 Preference for survival
  ACCEPTABILITY
	 Vulnerability (ethical)
	 Perceived usefulness and the idea 
of benefit (socio-cultural)
	 Knowledge and understanding of 
the technology (i.e. home-based 
palliative care, socio-cultural)
	 User-professionals-relationships  and 
decision making (socio-cultural)
  MEANINGFULNESS
	 Context and implementation issues  
  FEASIBILITY 
	 Access and availability (ethical)
	 Voluntariness (ethical)
  APPROPRIATENESS 
fic assessment criterion. In addition, issues that may 
influence the internal/external validity of the findings 
were reported according to the information provi-
ded by the evidence summaries. Evidence from these 
summary tables was presented to the decision making 
committee in the case study. However, after feedback 
in the meeting, internal and external review, we sub-
sequently developed the extended logic model to as-
sist decision making (see Figure 2). The extended logic 
model to assist decision making is based on evidence 
summaries from the assessment of effectiveness, eco-
nomics, acceptability, meaningfulness, feasibility and 
appropriateness. This was not tested in the case study 
but is included as an example of how the case study 
application assisted the development of the methods 
in the project. To assess the applicability of the in-
tervention assessed in the HTA in a specific context, a 
rapid applicability assessment was conducted within 
Step 4. A consultation guide for the applicability as-
sessment based on the CICI framework was applied 
within the case study in three countries (the U.K., Ger-
many and Poland).
2.9.5  How to read the extended logic 
model to assist decision making
The assessment criteria (effectiveness, meaningfulness 
etc.) are symbol coded (see Figure 1). Evidence relating 
to each assessment criterion is coded by the same sym-
bol and assigned to either context (legal, ethical and 
socio-cultural evidence) or implementation outcomes 
(effectiveness and cost effectiveness evidence, patient 
preferences and moderators of treatment effect). Where 
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Table 2  The complexity characteristics of reinforced home based palliative care.
Characteristic Application to palliative care 
1  Multiple and changing  
perspectives
Stakeholders include:
•  Patients, carers and families. Though palliative care engages with customers 
holistically, each individual will have different perspectives reflected in their 
goals. 
•  Health and social care professionals, people working in the charitable and 
voluntary sectors.
•  Local and national health and social care managers and policy makers, cha-
ritable and voluntary sectors agencies managers and policy makers.
•  All stakeholders have differing perspectives related to goals and outcomes. 
2  Indeterminate phenomena •  The philosophy of individualised palliative care that responds to patient 
and caregiver preferences means that interventions should be flexible and 
tailored to individual need. Patient and carer needs will change over time, 
meaning that palliative care has to be flexible to changing circumstances. 
Furthermore, the concept of palliative care has evolved over time, initially 
being associated with cancer and more recently evolving to be appropriate 
for patients with any life-threatening or life-limiting illness.
•  Home based palliative care is not one single clearly defined/delimited in-
tervention 
•  Similarly reinforced carer support is not a single well defined intervention 
and may contain elements of support that are routinely provided within 
conventional care (e.g. informal training/education of carers). 
3  Uncertain causality •  The COPE intervention within the set of reinforced home palliative care in-
terventions was unique in having an explicit underpinning theory. However 
complexity of context makes the interpretation of empirical evidence base 
difficult, even well designed trials have difficulty determining causality. 
•  Care providers from a range of agencies work with patients who have many 
different diseases and illness trajectories any combination of which may 
interact differently with the causal chain of the intervention. Additional 
difficulties for evaluation include ethical concerns about manipulating in-
terventions considered to be beneficial to patients along with pragmatic 
problems of recruitment, attrition, data collection and missing data.
4  Unpredictable outcomes •  Over 500 outcome measures are used in palliative care. Hence, there is often 
a lack of consistency with regard to which outcomes are measured and the 
tools used to do this.
•  Additionally, there is uncertainty about which outcomes are most appropri-
ate for the wide range of stakeholders, and how to balance these, especially 
if they are conflicting.
5  Historicity, time and path 
dependence
•  Palliative care has changed over time and the philosophy of individualised 
care limits the generalizability and repeatability of an intervention.
•  The palliative care context within which the reinforced carer support inter-
vention might act is dynamic. 
•  Note the extent of these dynamic aspects would vary even throughout the 
UK. Internationally the palliative care systems would potentially commence 
from very different starting points. 
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Box 1  Key results of the case study for HTA
Integration was enhanced in a number of ways within this case study. For example, use of the INTEGRATE-HTA  Model 
provides a unifying framework for integration by organising diverse methods in a step based process. The INTEGRA-
TE-HTA Model provides a useful structure for this report and could contribute to the future development of “integ-
rated HTAs” by assisting the integration of different assessment aspects of complex technologies (i.e. effectiveness, 
economic ethical, legal and socio-cultural aspects as well as patient preferences, moderators of treatment outcomes 
and issues relating to context and implementation). It also assists the integration of stakeholder perspectives in HTA.
Integration was further assisted through the application of the CICI framework in the logic model and as the 
“best fit framework” in the qualitative review.
In the Demonstration-HTA, important aspects of home based palliative care were assessed including barriers 
and facilitators to the implementation of home based palliative care. 
Identifying the most important assessment criteria at the outset of an HTA is valuable in assisting decisions 
about how to integrate subsequent evidence collection. 
The logic model provided a flexible method to describe the system in which interactions between the partici-
pants, the intervention and the context occurs in home based palliative care. This enabled us to conceptualise 
the complexity of reinforced and non-reinforced home based palliative care.
Our understanding of complexity and the implications for HTA methods developed through application of the 
economic, ethical and socio-cultural economic assessments, which enabled identification of the complexity 
characteristics of rHBPC and HBPC and the palliative care system.
Information and advice gathered from lay and professional stakeholders in seven countries assisted in the identification 
of shared issues of importance in several countries. The added value of stakeholder involvement throughout the HTA 
process has been illustrated through the additional insights that they provided for researchers with regard to identifying 
priorities in palliative care and validating some of the findings presented (e.g. patient preferences, moderators of treat-
ment effect). Additionally, they provided colloquial (informal) evidence based on their experiential knowledge to inform 
gaps in the evidence (e.g. effectiveness). This colloquial evidence can complement other types of evidence to enhance 
understanding of the technology, its application and its implications for practice and further research. 
A variety of approaches were used to involve stakeholders, some of whom were vulnerable, in this case study. 
Extensive lay and professional stakeholder consultation took place in a number of different ways (i.e. face-face, 
via telephone and email and in a Skype meeting), throughout the case study, enabling the added value of their 
input into HTA to be identified. In addition to assisting in identifying the topic for the case study, stakeholder 
advice can complement and enrich traditional forms of evidence to provide additional insights into the eviden-
ce base without creating heavy workload demands for researchers or stakeholders themselves. 
Although policy directives encourage stakeholder involvement in HTA, opinion about the ‘best’ methods of sta-
keholder involvement vary internationally. Methods and evaluation criteria for qualitative research approaches 
for stakeholder involvement are well documented. However, there is scope for further development of methods 
and evaluation criteria for consultative approaches to stakeholder involvement. 
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an outcome consists of evidence from the assessment 
results of more than one assessment aspect (e.g. legal, 
ethical etc.), the outcome is assigned to several areas in 
the extended logic model to assist decision making. For 
instance, the outcome “Autonomy and shared decision 
making” was located in four different assessment as-
pects as the underlying evidence was obtained from the 
assessment of these four different aspects (legal issues, 
ethics, patient preferences, socio-cultural aspects).
2.9.6  Step 5 - HTA conclusion 
Step 5 results in the HTA conclusion and recommenda-
tions. A mock decision making meeting was organised 
using Multiple Criteria Decision Analysis (MCDA), one 
method that may be used to support decision making 
in HTA. A group of 13 stakeholders (including 11 pro-
fessionals involved in commissioning end of life ser-
vices and two lay stakeholders in England) took part in 
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the meeting. MCDA guides stakeholders to weight the 
assessment criteria (effectiveness, cost effectiveness, 
acceptability etc.) based on a generic description of 
them. Stakeholders then scored the HTA results on a 
scale from +5 to -5 to indicate whether the inter-
vention (i.e. reinforced home based palliative care) 
is “significantly better” or “significantly worse” than 
non-reinforced home based palliative care. A decision 
could not be finalised due to the limited time availa-
ble. However, participants were still able to highlight 
a number of important issues related to the benefit of 
rHBPC and the relevant evidence that we had identi-
fied in the case study. For final decision making, the-
se issues (e.g. difficulties in differentiating between 
reinforced and non-reinforced home care) should be 
taken into account.
3 RESULTS
3.1  KEY RESULTS OF THE CASE 
STUDY FOR HTA
Some of the concepts and methods developed in the 
INTEGRATE-HTA project have been successfully applied 
to an assessment of rHBPC and HBPC in this case study, 
suggesting that these are feasible and a potentially 
valuable addition to HTA methods. 
3.2 KEY RESULTS OF THE CASE  
STUDY FOR PALLIATIVE CARE 
The key results relating to the Demonstration-HTA of 
reinforced and non-reinforced models of home based 
palliative care are summarised in Box 2 with referen-
ce to each assessment criterion of the HTA-research 
question. These findings are based on the application 
of some key parts of the INTEGRATE-HTA guidances for 
the assessment of complex health technologies. Some 
gaps in the assessment will mean that the findings 
should be considered cautiously.  Due to overlaps 
between the assessment criteria “Meaningfulness”, 
“Appropriateness” and “Acceptability”, evidence re-
lated to these terms needs to be read in conjunction 
with each other.
4 DISCUSSION
4.1  KEY STRENGTHS OF THE CASE 
STUDY 
The case study has several strengths. Not only is home 
care a timely topic of relevance to stakeholders, the 
case study reveals the complexity of designing inter-
vention studies in palliative care contexts. The case 
study demonstrates the potential value of some of 
the many concepts and methods developed by a mul-
tidisciplinary HTA research team within the INTEGRATE- 
HTA project. This includes demonstrating the value of 
the INTEGRATE-HTA Model as a unifying framework for 
integrating evidence from a variety of sources. The 
updated literature review about models of palliative 
care is helpful to those working in the field. This case 
study indicates the value of using Harvest plots as a 
methodological approach where meta-analysis is not 
appropriate or feasible. The economic analysis offers a 
provisional costing model that HTA researchers can use 
when considering the design of evaluative research of 
palliative care interventions with elements of carer 
support. The ethical analysis is helpful in highlighting 
the assumptions about family carers and the potential 
for undue pressure being placed upon them to contri-
bute to home care.  
Extensive lay and professional stakeholder consulta-
tions across seven countries is a major strength as the 
project focuses on a topic that is potentially relevant 
to a number of stakeholders in several countries.  The 
case study indicates that a variety of methods can be 
used to engage stakeholders, and appear to be ac-
ceptable and effective in terms of providing stakehol-
ders with a valuable voice within HTA. The presenta-
tion of new and novel evidence about reinforced and 
non-reinforced models of palliative care in a com-
prehensive manner may direct future research acti-
vity and assist decision making about commissioning 
future palliative care services. 
4.2  KEY LIMITATIONS OF THE  
CASE STUDY 
Despite its strengths, the case study was hampered 
by not being associated with a “real world” de-
cision making process, as the assessment criteria 
and integration process was not explicit at an early 
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Box 2  Key results of the case study for palliative care
Effectiveness: The effectiveness evidence suggests that reinforced models of home based palliative care 
show largely inconsistent effects. Most studies show no effect for reinforced home based palliative care 
interventions compared to non-reinforced home based interventions with respect to patient and care-
giver outcomes. Some positive effects were seen for patient symptom control and psychological health 
outcomes, as well as for caregiver quality of life, psychological health and response outcomes. However, 
the overall impact appears to be neutral for both patient and caregiver outcomes. The gap analysis and 
the expert consultations complemented evidence from the primary studies, suggesting that the results 
may have arisen for a variety of reasons. These reasons include the heterogeneous nature of usual (i.e. 
non-reinforced) care, which is individually tailored for patients and informal carers throughout the ill-
ness trajectory along with the assessment of outcomes that may not reflect the purpose of the interven-
tion and inappropriate choice of research design.
Moderators of treatment effect: The limited evidence about moderators of treatment effect for rHBPC and HBPC 
suggests that attention should be given to patient survival, place of death and informal caregiver’s psychological 
health in terms of manageability and grief. 
Economics: The economic analysis considered the impact of introducing a specific reinforced carer support 
intervention – the COPE intervention - as a new component within a home palliative care system in England. 
The marginal impact on resource use and costs were modelled and should be considered in conjunction with 
the detailed analysis of effectiveness presented separately.  The economic analysis was based on a National 
Health Service (NHS) and Personal Social Services (PSS) perspective; patient and carer costs were not included 
in this case study. The results of the economic analysis suggest that the addition of reinforced carer support 
interventions in home-based palliative care may be cost saving, but these provisional estimates are based 
only on an elicitation exercise and are subject to significant uncertainty. The largest component of projected 
cost savings arises from the potential to reduce avoidable emergency admissions to hospital by providing 
formal training and support to the carer. However, many potential barriers to realising these savings exist. 
Interventions to support carers need to be considered within wider initiatives to provide co-ordinated palli-
ative care, with mechanisms to review and adapt the design of the reinforcement components.
Acceptability: Evidence for acceptability comes from the ethical, legal, socio-cultural assessments and 
the assessment of patient preferences, including both patient preferences for how care is provided and 
for specific treatment outcomes. Most patients prefer quality rather than quantity of life and would 
prefer to die at home. The ethical assessment identified access and availability as issues influencing the 
acceptability of rHBPC and HBPC. Both the ethical and socio-cultural assessments identified that rHBPC 
and HBPC results in changing roles and relationships for patients and informal carers, both of whom 
may experience stigma and loss of social status. Additionally, relationships with healthcare professionals 
may also change. Findings from the assessment of socio-cultural aspects indicate that informal carers 
may lack clarity about their responsibilities, lack training for their role, experience role conflict and suf-
fer illness as a result of care giving which may be influenced by additional caregiver support in rHBPC. 
rHBPC and HBPC pose challenges to carer voluntariness (willingness to take on the role), shared decision 
making and patient and carer autonomy and conflicts of interest can arise between patients and family 
carers the latter also being raised as a concern in the legal assessment. Reducing the burden on families 
is important as is the desire to preserve autonomy. rHBPC aims to provide support to informal carers and 
could change the way informal carers deal with the situation as well as how professional carers value the 
role of informal carers and the related burden. The socio-cultural assessment indicated that rHBPC may 
empower informal carers to make an informed decision about taking over or continuing the caring role. 
However, these effects are uncertain and rHBPC may be problematic in terms of ensuring informed con-
sent and preserving patient autonomy. Not only is there a risk that family pressure may oppose the patient's 
free informed consent or dissent, conflicts of interest can arise between patients and family carers. The dual 
role of family members as carers as well as a source for substituted informed consent and the higher number of 
people that might be involved and need access to the patient's data may also influence acceptability. 
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Meaningfulness: Evidence for meaningfulness also comes from the ethical and socio-cultural assessment. 
Both assessments identified that patients requiring rHBPC and HBPC are vulnerable as palliative care is 
associated with stigma. The patient centred approach and individual relationships that rHBPC and HBPC 
offers patients, carers and professionals are valued by stakeholders. rHBPC and HBPC offer benefits for 
patients who feel safe and secure, as well as for relatives who can be close to the patient and manage 
their lives without the added burden of hospital visits. rHBPC and HBPC allow professionals to provide 
individualised care. Although much of the information collected was positive, it is worth noting that 
concerns were expressed in the socio-cultural assessment about the lack of understanding about the 
term palliative care and lack of clarity about when and how to access palliative care. Additionally carers 
reported concerns that their request for services was limited to what they know about and the ‘battles’ 
to gain information and funding had negative consequences for their own health. These issues may be 
positively influenced by additional support through rHBPC. 
Appropriateness: Evidence from the ethical and the socio-cultural assessment informs appropriateness. 
Concerns exist abut fairness and equity in terms of the just distribution of palliative care services and 
the access and availability of palliative care, particularly HBPC due to the lack of availability of services 
and specific professionals. This is compounded by concerns about defining “end of life care” which can 
lead to uncertainties concerning access to rHBPC and HBPC. Service access may vary geographically. Easy 
(e.g. out of hours), equitable (e.g. to all groups, irrespective of diagnosis) and timely (e.g. not restricted 
only to the last months of life) access to palliative care and support for family carers post bereavement is 
required. Home based palliative care may challenge carer autonomy with regard to voluntariness of role 
acquisition and the implementation, use and withdrawal of home based palliative care services. The so-
cio-cultural assessment highlights a number of reasons for difficulties in access to palliative care, raising 
concerns that access to HBPC and rHBPC can become an issue of social inequality. 
Feasibility: Evidence from the qualitative review, ethical and socio-cultural assessments inform feasi-
bility. The successful delivery of home based palliative care relies on the provider, the organisation and 
structure in which they are embedded, as well as the micro-context of the family and home in which a 
palliative care patient and his family are living. A number of barriers and facilitators to the implemen-
tation of home based palliative care were identified in a qualitative review. Additionally, the ethical 
assessment highlighted the need for shared decision making at the outset of HBPC, acknowledging that 
this challenges patient and carer autonomy as the result of communication difficulties arising from a 
variety of causes (e.g. patient capacity, physician / staff paternalism or restrictions on choices available). 
All three assessments indicated that informal care imposes a burden on the lay caregiver, who needs to be 
willing to undertake the role and supported in it. However, the informal carer’s needs for support fail to 
be identified or addressed for a variety of reasons; some related to informal carers’ lack of willingness to 
disclose their needs and others relating to professional carers’ inability to identify caregiver needs, lack 
of training, resources and structural barriers. The socio-cultural assessment suggests that the feasibility 
of HBPC is associated with the number of agencies involved in providing care and the degree to which 
services are co-ordinated, which may be influenced by professional training, cultures and co-operation 
styles.  Furthermore, access of the informal caregiver to the health and social system, difficulties in na-
vigating the system as well as barriers to actually utilizing them were recurrent themes in the qualitative 
review.
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stage. This made integration more difficult after 
the identification and synthesis of evidence. Re-
source constraints influenced the degree to which 
the concepts and methods developed within the 
INTEGRATE-HTA project have been tested. Limited 
quantity and quality of evidence exists about rein-
forced and non-reinforced models of home based 
palliative care and there was little directly rele-
vant evidence in some aspects of the assessment. 
Consequently, the case study findings are heavily 
reliant on a limited number of a number of lay 
and professional stakeholders with experience and 
expertise in palliative care. Difficulties arose in 
achieving a shared understanding about palliative 
care terms and the interventions of interest among 
the research team and with the diverse range of 
international stakeholders. For example, the term 
‘reinforced’ care is not widely recognised by cli-
nicians or policy makers. Similarities and overlaps 
between reinforced and non-reinforced home-ba-
sed models of palliative care and the fact that these 
terms are not widely recognized or used in practice 
made assessment particularly difficult. This, coupled 
with poor descriptions of the heterogeneous mo-
dels in the literature, resulted in some lack of cla-
rity about the intervention and comparator for sta-
keholders. The U.K. focus for the case study means 
that there needs to be careful consideration before 
it can be generalised to other countries in Europe 
or beyond.  Palliative care needs to be understood 
in the cultural, economic and healthcare system in 
which it is embedded as acknowledged in the analy-
sis of socio-cultural aspects of HTA.
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Box 4  Conclusions for palliative care
Reinforced and non-reinforced home-based palliative care have all the characteristics of complex health tech-
nologies. The existing evidence about rHBPC and HBPC is limited in terms of quantity and quality. The evidence 
that does exist is too limited to draw firm conclusions about whether reinforced models are more acceptable, 
feasible, appropriate, meaningful, effective, cost-effective and patient-centred models than non-reinforced 
models of home based palliative care for adults. 
6 RECOMMENDATIONS FOR HTA
The case study report has provided useful insights in the application of the methods and concepts developed in 
the INTEGRATE-HTA project report. Based on the results of the Demonstration-HTA, recommendations for HTA are 
shown in Box 5. 
Box 3  Conclusions for HTA
The case study demonstrates the application of some of the concepts and methods developed within the INTEG-
RATE-HTA project to the assessment of rHBPC and HBPC, as one example of a complex health technology. Findings 
suggest that all of the concepts and methods applied in this case study appear to be feasible and potentially 
valuable additions to HTA methods.
However, a number of shared difficulties undermined the development of an integrated HTA, including simila-
rities between, and poor descriptions of, both intervention and comparator models within the evidence base. 
This created uncertainty for researchers trying to differentiate between rHBPC and HBPC for assessment using 
evidence review. Furthermore, the heterogeneous nature of rHBPC and stakeholders’ lack of familiarity with the 
term ‘reinforced’ palliative care resulted in lack of clarity and shared understandings of rHBPC and HBPC. 
The limited amount and quality of evidence available about rHBPC and HBPC restrict the conclusions that can be 
drawn from the case study. As such, careful interpretation is required when considering the case study results. 
Further application of the concepts and methods developed within the INTEGRATE-HTA project in the assessment 
of other complex technologies is warranted. 
Box 5  Recommendations for HTA
1   Integration should be taking place from the very beginning: Framing of the HTA question, and developing 
this in light of the understanding of the system within which the intervention will be implemented, is the 
very first step for an integrated HTA. In particular, consideration should be given to how the assessment 
criteria of the HTA research question will be informed by the evidence collected. Accordingly, the different 
assessment aspects should be considered to address overlaps between the assessment results (e.g. assess-
ment results regarding patient characteristics can feed into the assessment of effectiveness). A “real world” 
decision making process will assist in making the assessment criteria and process explicit at an early stage.
5 CONCLUSIONS
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Further work is needed to ensure that consideration has been given to the integration process well before 
specific elements of the evidence required for the HTA are identified. 
Stakeholder consultation is required to develop an understanding of the most important issues to address 
in the HTA. Involving stakeholders throughout the HTA process is important for researchers to gain additional 
perspectives that assist in the interpretation of evidence. Stakeholder consultation provides insights into the 
criteria that they consider to be important in decision making; information that could assist decision makers 
within each context and for each HTA question posed.
2  Complexity characteristics of the intervention should be assessed and taken into consideration throug-
hout HTA: The complexity characteristics of the intervention may not be apparent at the outset and their 
relevance and significance may emerge during the evidence synthesis process. It is important that an as-
sessment of complexity characteristics is undertaken and a common understanding of the intervention’s 
complexity is established in the research team. 
3   Stakeholder involvement throughout the HTA process should be encouraged: Researchers should involve 
stakeholders throughout the HTA process to ensure that their experience and expertise informs the focus of the 
HTA, the evidence and interpretation of the the evidence. This includes careful consideration of the range and 
diversity of different stakeholders who may usefully inform the HTA process.
Stakeholder involvement should be planned at the outset of the project. Attention should be given to the 
most appropriate methods of stakeholder involvement and the co-ordination of stakeholder involvement in 
HTA. Co-ordination issues should specifically consider whether stakeholder input can be shared amongst the 
assessment aspects (e.g. for the assessment of economic and ethical aspects) or whether each aspect requires 
separate stakeholder involvement. Stakeholder involvement also needs to be timely with regard to the activity 
(e.g. to coincide with development of the project scope or analysis of the findings). 
International stakeholder consultation requires understanding of different philosophies and recommendations 
about the best approaches to stakeholder involvement in each country. Different approaches to involvement 
require different ethical approvals; the use of different methods and language to describe research / invol-
vement activities. International research teams involving stakeholders in different countries should pay par-
ticular attention to methods used for the synthesis of information obtained through stakeholder consultation 
and the interpretation of the findings. The advice provided by stakeholders should be viewed as colloquial 
(informal) evidence based on experiential knowledge. Methods need to be developed to evaluate the impact 
of stakeholder involvement in HTA, especially in areas where both the quantity and quality of the evidence is 
limited. 
The purpose, timing and methods of stakeholder involvement are crucial if it is to be feasible, acceptable and 
effective. Better understanding should be developed, through further research, of the value of lay stakeholder 
input into HTA and how best to elicit their views by developing a range of methods and evaluation criteria. 
For example, lay and professional stakeholders provide heterogeneous perspectives and valuable insight and 
understanding of the technology, which saves time. Stakeholder contributions to the HTA should be adequately 
resourced in terms of manpower, time and finance to ensure realistic expectations of what can achieve.  
The purpose and potential impact of stakeholder consultation should be clearly articulated to all stakeholders 
so that everyone involved has realistic and shared expectations about this. Consideration should be given to 
the potential positive, negative, short and long term impact of stakeholder involvement in terms of reach and 
significance. A dialogue should be established with stakeholders throughout the project. Feedback should be 
given to stakeholders about the value of their input into the HTA process and the changes made as a result of 
the advice or information they provide. An explanation should be given to stakeholders for decisions made, 
particularly if this conflicts with the advice and information they provide.  
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4   The methods and concepts developed within the INTEGRATE-HTA project should be applied to other com-
plex technologies: The methods developed in the INTEGRATE-HTA project should be applied to other complex 
technologies by HTA researchers. This is essential to demonstrate their value in an HTA undertaken in a “real 
world” rather than a methodological research project setting. Further case studies could also test their value 
in different types of HTA and in assessing different technologies and evaluate the extent to which they are 
found to be feasible and useful by both those undertaking, and acting on, the findings of more integrated, 
patient-centred HTA methods.
7 KEY MESSAGES AND  
RECOMMENDATIONS  
FOR PALLIATIVE CARE
A number of key messages were identified for service com-
missioners, health and social care practitioners, academics, 
carers and service users in the case study. The messages are 
of interest to all stakeholders (not exclusive to each group), 
although some may have more relevance to specific groups. 
Before reading the key messages and recommendations ari-
sing from the study (see box 6), we provide an overview of 
what is known about palliative care for readers who are not 
familiar with this (see bullet points below).
 	 European populations are ageing; people are living with 
more complex, chronic conditions and a greater number 
of co-morbidities. Many people with chronic conditions 
have palliative care needs. 
 	 Palliative care aims to relieve suffering and improve qua-
lity of life for both patients and families throughout a life 
limiting illness, not just at the end of life. Palliative care 
is highly complex as it is interdisciplinary and holistic in 
nature (i.e. addresses physical. psychological, social, spi-
ritual and emotional needs) and treats the patient and 
family as the ‘unit of care’. Palliative care also provides 
support for family carers post bereavement.
 	 In the U.K. (the context for the case study), palliative care 
is delivered by two distinct categories of health and social 
care professionals: specialist and generalist palliative care 
providers. ‘Generalist palliative care’ providers are health 
professionals who have not received specific training in 
palliative care, but routinely provide health care for pa-
tients at the end of their lives, which may include gene-
ral practitioners, community nurses, nursing home staff 
and hospital staff. ‘Specialist palliative care’ is provided 
by teams of multidisciplinary palliative care professionals 
who have undertaken specialist training in palliative care 
and work only within the field of palliative care. 
 	 Informal carers have a key role in supporting people 
with palliative care needs, including those approaching 
their end of life. Informal carers are lay people in a clo-
se supportive role who undertake vital care work and 
emotional management, although they may or may not 
be family members. Care is often provided by a complex 
network of family, friends and neighbours, each con-
tributing different aspects of practical and emotional 
care, and economic resources. Not all families may be 
functional or supportive and not all homes may be safe, 
comfortable or well equipped for end of life care. Much 
evidence shows patients have a preference for care and 
death at home. Interventions should, therefore, reflect 
this preference by aiming to deliver care outside insti-
tutional settings where possible to enable patients to 
remain at home if desired. 
 	 Care at home can be rewarding for those closest to the 
patient, including the informal caregiver. However, the 
role of informal carers differs in each family and is known 
to change over time. Providing home care may increase 
the burden of informal caregivers close to the patient, 
causing physical, psychological and social stress both du-
ring care and after the death of the patient.
 	 Providing support for informal carers is important is im-
portant as informal carers are known to suffer high levels 
of stress and burden as a result of their caregiving res-
ponsibilities. Caregiver stress and burden may result in a 
breakdown of informal caregiving and increase costs and 
health service use should the carer become ill themselves 
or unable to continue in their role. 
 	 The need to support informal carers in their caregiving 
role is important and widely acknowledged in policy and 
service commissioning documents.
 	 There may be a limited window of opportunity to support 
informal carers, whose needs may change over time and 
with the patient’s condition and their own healthcare 
needs. Additionally, the provision of support for informal 
caregivers relies on them being identifed and many peo-
ple do not consider themselves to be ‘carers.’ 
 	 Practitioners should assess each individual’s willingness 
(voluntariness) to take on the informal caregiving role 
and their needs for support before they commence in 
role.
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Box 6 Key messages and recommendations for palliative care 
1   Home based palliative care services have been developed with and without an additional component of caregiver 
support. These models are known as “reinforced” (rHBPC) and “non-reinforced” home based palliative care (HBPC) 
respectively. Although diverse (heterogenous) in nature, reinforced (rHBPC) and non-reinforced models of home based 
palliative care (HBPC) may be similar in several respects.  HBPC models primarily focus on patients, though support 
may also be directed towards caregivers on an ad hoc basis rather than as specific planned intervention. rHBPC will 
always include an intentional, explicit attempt to support informal caregivers in addition to the care given to pati-
ents. ‘Support’ is broadly defined as any psycho-educational intervention aimed at providing assistance to caregivers 
(e.g. individual or group counselling, education, advice or respite services).  Hence, this support may be more active 
in nature, aiming to prepare the caregiver for the patient care to come, by teaching the necessary skills, or it may be 
reactive in nature, aiming to address psychological health burden of the lay caregiver resulting from care. Some rein-
forced models are underpinned by specific theories, such as stress-coping while others may not be based on theory. 
2   Professionals should be alert to carer’s needs for support and consider ways that their needs can be met.
3  Decision makers need to further consider how best to support informal carers and where possible, support should 
reflect the needs and preferences of both patients and carers. There is a limited amount and quality of research 
evidence about all aspects of reinforced (rHBPC) and non-reinforced home based palliative care (HBPC) on which 
to base decisions about which services should be commissioned. Poor reporting about the components of rHBPC 
and HBPC hinders comparisons of the interventions, increasing limitations relating to the volume of available 
evidence. Additionally, stakeholders’ lack of familiarity with the term ‘reinforced’ palliative care resulted in lack 
of clarity and shared understandings of rHBPC and HBPC. 
Reinforced home-based palliative care interventions were neither better nor worse than non-reinforced ho-
me-based care with respect to patient outcomes and most showed no effect across caregiver outcomes. It is 
possible that the outcome measures used are not sensitive enough to detect relevant effects in this population. 
In the absence of cost effectiveness data, expert elicitations provided insight into costs of reinforced home based 
palliative care. Cost data supports the implementation of home based models of palliative care with the potential 
to be cost saving, largely because of an expected reduced need for hospitalization of the patient who is being 
cared for by the recipient of rHBPC. 
4   In addition to cost and clinical effectiveness evidence, decision makers should take account of other types of 
evidence that may assist in capturing the complexity of palliative care. Decision makers indicated their desire to 
take account of a wider range of evidence. Doing so relies on HTA researchers’ ability to undertake assessments 
of a variety of aspects (e.g. socio-cultural, legal and ethical issues; context and implementation issues as well as 
patient preferences).
5  Although most patients prefer quality rather than quantity of life and to die at home, evidence suggests that sing-
le patients who live alone are less likely to die at home. Patients without caregivers; with uncontrollable physical 
symptoms; where physicians may not be available or where concerns exist about responding to sudden changes 
are also less likely to die at home. 
6  Although most patients prefer to die in the security of their own home, determining the acceptability, meaning-
fulness and appropriateness of rHBPC and HBPC proved challenging in light of the limited quality and quantity of 
evidence about models of home based palliative care and challenges associated with HBPC. 
7  In terms of acceptability, the challenges associated with home based palliative care for informal caregivers inclu-
de adapting to changing roles and relationships amongst the patient-carer dyad and professionals; preserving 
patient and informal caregiver independence in decision making (autonomy) and avoiding caregiver burden. 
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8  Practitioners, informal carers and patients should be alert to the effects of home based palliative care in terms of 
changing roles and relationships, the possible  stigma and loss of social status experienced and burden that this 
may impose on the lay carer.
9  In terms of meaningfulness, the challenges associated with home based palliative care relate to alleviating the 
carer burden and subsequent ill health. 
10  As a priority, informal carers need equitable access to high quality, flexible services that are able to respond to 
individual needs and circumstances. A number of interventions and services have been developed to support 
informal carers. However, concerns exist regarding the availability, accessibility and equity of palliative care pro-
vision and the challenges this poses to carer autonomy. Tailored, responsive support may be needed because each 
family and caregiving situation is unique. 
11  In terms of feasibility, a number of barriers and facilitators exist to the implementation of home based pal-
liative care, notably in supporting informal carers in their role. These barriers and enablers related to the 
provider; the organisation and structure in which they are embedded as well as the micro-context of the 
family and home in which a palliative care patient and his family are living. For example, communication 
difficulties arise from a variety of causes (e.g. patient capacity, physician / staff paternalism or service res-
trictions on choices available). Lay carers’ willingness to undertake the role and be supported in it influences 
the situation. Some barriers related to informal carers’ lack of willingness to disclose their needs and other 
barriers related to professional carers’ inability to identify carer needs, lack of training or resources. The 
feasibility of HBPC is associated with the number of agencies involved in providing care and the degree to 
which services are co-ordinated, which may be influenced by professional training, cultures and co-operati-
on styles.  Furthermore, access of the informal carer to the health and social system, difficulties in navigating 
the system as well as barriers to actually utilizing them were often reported. All these issues need to be 
considered when making decisions about how best to support patients and their carers. 
12  Decision makers, service providers, practitioners, informal carers and patients require a clear understanding 
of the potential barriers and facilitators of home based palliative care and strategies need to be developed 
to overcome the barriers (e.g. equity of access, providing information and assisting informal carers to navi-
gate the health care system). 
13  Interventions to support carers need to be considered within wider initiatives to provide co-ordinated 
palliative care, with mechanism to review and adapt the design of the reinforcement components.
14  The limited amount and quality of evidence that was available about rHBPC and HBPC and the lack of directly 
relevant evidence in some aspects of the assessment impeded the conclusions that can be drawn from the 
application of the application in this case study. As a result, the case study findings are heavily reliant on a 
limited number of experts. Careful interpretation is required when considering the case study results.
15  Differences in palliative care provision across Europe means that careful consideration is required in order to 
determine which, if any, of the findings could be potentially applicable across Europe.
16  Further evidence is required about all aspects of home based models of palliative care assessed in this HTA 
case study. With regard to research examining the effectiveness of home based models of palliative care, 
careful consideration should be given to outcome measures to ensure that these reflect the purpose of the 
intervention, the choice of research design and patient and carer perspectives about what is important. 
There is a need for more research to understand how support might best be tailored to meet the different 
circumstances and specific needs of different patients and carers.
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17  Service commissioners should consider the use of mixed methods, qualitative research and action research as 
a potential way of evaluating services.  Randomised controlled trials and other types of experimental evidence 
are often not feasible in palliative care and action research methods are also a useful way to engage with local 
clinicians, patients and informal carers, who are key stakeholders, in the process of service development. 
18  Better reporting of the components of reinforced and non-reinforced models of palliative care is required in 
primary studies and for review level evidence. With some adaption of the tool, this could be achieved using the 
TIDiER framework (Hoffmann et al., 2014) in primary research studies as well as reviews. This will enable decision 
makers to determine the resource implications associated with replicating models
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